Keyphrases
PI3K Signaling
100%
Lethality
100%
Histone Acetylation
100%
Dual Inhibition
100%
Mantle Cell Lymphoma
100%
Lymphoma Cells
41%
Ibrutinib
41%
Phosphoinositide 3-kinase (PI3K)
16%
Lymphoma Patients
16%
Dysregulation
8%
Immunoblotting
8%
Additive Effect
8%
Molecular Mechanism
8%
Synergistic Effect
8%
Bruton's Tyrosine Kinase
8%
Apoptosis
8%
Primary Cells
8%
Chromatin Immunoprecipitation (ChIP)
8%
Therapeutic Potential
8%
Unmet Medical Need
8%
Poor Outcome
8%
Protein Array
8%
Chronic Lymphocytic Leukemia Cells
8%
Mouse Xenograft Model
8%
Medicine and Dentistry
Lethality
100%
Histone
100%
Mantle Cell Lymphoma
100%
Ibrutinib
100%
Histone Acetylation
28%
In Vitro
14%
Programmed Cell Death
14%
B-Cell Chronic Lymphocytic Leukemia
14%
Immunoblotting
14%
Xenograft
14%
Chromatin Immunoprecipitation
14%
Protein Microarray
14%
Bruton Tyrosine Kinase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Lethality
100%
Histone
100%
Mantle Cell Lymphoma
100%
Ibrutinib
58%
Mouse Model
8%
Western Blot
8%
Chronic Lymphatic Leukemia
8%
Chromatin Immunoprecipitation
8%
Bruton Tyrosine Kinase
8%
Biochemistry, Genetics and Molecular Biology
Deacetylation
100%
Histone
100%
Histone Acetylation
28%
Bruton Tyrosine Kinase
14%
Primary Cell
14%
Chromatin Immunoprecipitation
14%
Mouse Model
14%
Protein Microarray
14%
Immunoblotting
14%
Programmed Cell Death
14%